Perfusion imaging plays an important role in management decisions for a variety of cerebrovascular diseases. Most clinical perfusion MRI of stroke requires the use of contrast agent. However, contrast-agent perfusion cannot be used or fails to be used in 10-20% of patients. Therefore, an alternative technique to Gd-perfusion will benefit a substantial number of patients in clinical practice. Recently, a MR-Fingerprinting (MRF) ASL was developed for simultaneous estimations of CBF and bolus timing. In this study, we demonstrated the clinical utility of MRF-ASL in two types of cerebrovascular diseases, ischemic stroke and Moyamoya disease.